SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Leonardo Simonella, Karen Canfell, Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries, Vaccine, 2015, 33, 1, 34

    CrossRef

  2. 2
    Yusuke Tanaka, Yutaka Ueda, Hisayo Kishida, Noriko Hosogai, Akiko Morimoto, Tomomi Egawa-Takata, Shinya Matsuzaki, Eiji Kobayashi, Kiyoshi Yoshino, Tadashi Kimura, Trends in the cervical cancer screening rates in a city in Japan between the years of 2004 and 2013, International Journal of Clinical Oncology, 2015,

    CrossRef

  3. 3
    Hiroyuki UCHIDA, Mizuki KOBAYASHI, Ami HOSOBUCHI, Ayano OHTA, Kazuo OHTAKE, Tutomu YAMAKI, Masaki UCHIDA, Youichi ODAGIRI, Hideshi NATSUME, Jun KOBAYASHI, Age, Period, and Birth Cohort-Specific Effects on Cervical Cancer Mortality Rates in Japanese Women and Projections for Mortality Rates over 20-Year Period (2012–2031), Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene), 2014, 69, 3, 215

    CrossRef

  4. 4
    Jonghyeon Choi, Yongjung Park, Eun Hee Lee, Sinyoung Kim, Jeong-Ho Kim, Hyon-Suk Kim, Detection and genotyping of human papillomavirus by five assays according to cytologic results, Journal of Virological Methods, 2013, 187, 1, 79

    CrossRef

  5. 5
    Leda Gattoc, Navya Nair, Kevin Ault, Human Papillomavirus Vaccination, Obstetrics and Gynecology Clinics of North America, 2013, 40, 2, 177

    CrossRef

  6. 6
    Gina S. Ogilvie, Sheona Mitchell, Musa Sekikubo, Christine Biryabarema, Josaphat Byamugisha, Jose Jeronimo, Dianne Miller, Malcolm Steinberg, Deborah M. Money, Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda, International Journal of Gynecology & Obstetrics, 2013, 122, 2, 118

    CrossRef

  7. 7
    Gina S. Ogilvie, Laurie W. Smith, Dirk J. van Niekerk, Fareeza Khurshed, Mel Krajden, Mona Saraiya, Vivek Goel, Barbara K. Rimer, Sandra B. Greene, Suzanne Hobbs, Andrew J. Coldman, Eduardo L. Franco, Women's intentions to receive cervical cancer screening with primary human papillomavirus testing, International Journal of Cancer, 2013, 133, 12
  8. 8
    Jerome L. Belinson, Hui Du, Bin Yang, Ruifang Wu, Suzanne E. Belinson, Xinfeng Qu, Robert G. Pretorius, Xin Yi, Philip E. Castle, Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing, International Journal of Cancer, 2012, 130, 8
  9. 9
    Jessica A. Kahn, Robert D. Burk, Kathleen E. Squires, Bill G. Kapogiannis, Bret Rudy, Jiahong Xu, René Gonin, Nancy Liu, Carol Worrell, Craig M. Wilson, Prevalence and Risk Factors for HPV in HIV-Positive Young Women Receiving Their First HPV Vaccination, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2012, 61, 3, 390

    CrossRef

  10. 10
    G S Ogilvie, M Krajden, D J van Niekerk, R E Martin, T G Ehlen, K Ceballos, L W Smith, L Kan, D A Cook, S Peacock, G C E Stuart, E L Franco, A J Coldman, Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study, British Journal of Cancer, 2012, 107, 12, 1917

    CrossRef

  11. 11
    Fernando Cobo, Human Papillomavirus Infections, 2012,

    CrossRef

  12. 12
    Charlene A. Wong, Mona Saraiya, Susan Hariri, Linda Eckert, Roberta I. Howlett, Lauri E. Markowitz, Julia M.L. Brotherton, Katy Sinka, Olga G. Martinez-Montañez, Susanne K. Kjaer, Eileen F. Dunne, Approaches to monitoring biological outcomes for HPV vaccination: Challenges of early adopter countries, Vaccine, 2011, 29, 5, 878

    CrossRef

  13. 13
    J. Monsonego, EUROGIN 2010 : feuille de route pour la prévention du cancer du col de l’utérus, Gynécologie Obstétrique & Fertilité, 2011, 39, 7-8, 462

    CrossRef

  14. 14
    Silvia Franceschi, Lynette Denny, Kathleen L. Irwin, José Jeronimo, Pier Luigi Lopalco, Joseph Monsonego, Julian Peto, Guglielmo Ronco, Peter Sasieni, Cosette M. Wheeler, Eurogin 2010 roadmap on cervical cancer prevention, International Journal of Cancer, 2011, 128, 12
  15. 15
    M. Schiffman, N. Wentzensen, S. Wacholder, W. Kinney, J. C. Gage, P. E. Castle, Human Papillomavirus Testing in the Prevention of Cervical Cancer, JNCI Journal of the National Cancer Institute, 2011, 103, 5, 368

    CrossRef

  16. 16
    AN Fiander, The prevention of cervical cancer in Africa, Women's Health, 2011, 7, 1, 121

    CrossRef

  17. 17
    R. Marshall Austin, Exhortations to abandon the Pap test as a routine initial cervical screening test are still premature and carry significant risks, Diagnostic Cytopathology, 2010, 38, 11
  18. 18
    Elisabete Weiderpass, Lifestyle and Cancer Risk, Journal of Preventive Medicine and Public Health, 2010, 43, 6, 459

    CrossRef

  19. 19
    S Franceschi, Monitoring HPV16/18 immunisation in England and elsewhere, British Journal of Cancer, 2010, 103, 2, 157

    CrossRef

  20. 20
    Kari J Syrjänen, Prophylactic HPV vaccines: the  Finnish perspective, Expert Review of Vaccines, 2010, 9, 1, 45

    CrossRef